These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3367854)

  • 41. [Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor].
    Pariente R; Rochemaure J; Murciano D; Brechot JM; Pappo M
    Therapie; 1988; 43 Suppl 4():361-4. PubMed ID: 3222777
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis.
    Boguniewicz M; Sampson H; Leung SB; Harbeck R; Leung DY
    J Allergy Clin Immunol; 2001 Oct; 108(4):651-2. PubMed ID: 11590398
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics and bactericidal activity of cefuroxime axetil.
    Ginsburg CM; McCracken GH; Petruska M; Olson K
    Antimicrob Agents Chemother; 1985 Oct; 28(4):504-7. PubMed ID: 3878129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cefuroxime axetil in the treatment of acute bronchitis in UK general practice.
    Stott P
    J Chemother; 1989 Jul; 1(4 Suppl):770-2. PubMed ID: 16312632
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
    Sasaki I; Morihana T; Kaneko A; Michi K; Takahashi K; Fukuoka F; Satoh T; Yoshinari N; Ohne M; Hara H
    Jpn J Antibiot; 1990 Dec; 43(12):2035-68. PubMed ID: 2086820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
    Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of cefuroxime axetil in patients with upper respiratory tract infections.
    Griffiths GK; VandenBurg MJ; Wight LJ; Gudgeon AC; Kelsey M
    Curr Med Res Opin; 1987; 10(8):555-61. PubMed ID: 3677790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Application of antibiotics zinnat and zinacef ("Glaxo Wellcome") in otorhinolaryngologic inflammatory diseases].
    Chufistov ME; Pavlenko SA; Chufistov VM
    Vestn Otorinolaringol; 1997; (1):44-5. PubMed ID: 9092170
    [No Abstract]   [Full Text] [Related]  

  • 49. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
    Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is oral cefuroxime axetil suitable for the treatment of unidentified bacterial infection of skin and soft tissue?
    Gudgeon AC; Vandenburg MJ; Wight LJ; Griffiths GK; Kelsey M
    Br J Clin Pract; 1987 Oct; 41(10):954-6. PubMed ID: 3505179
    [No Abstract]   [Full Text] [Related]  

  • 51. Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis.
    Gooch WM; Swenson E; Higbee MD; Cocchetto DM; Evans EC
    Clin Ther; 1987; 9(6):670-7. PubMed ID: 3125976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Laboratory and clinical studies on cefuroxime (author's transl)].
    Nishimura T; Hiromatsu K; Takashima T; Tabuki K; Kotani Y
    Jpn J Antibiot; 1979 Dec; 32(12):1211-8. PubMed ID: 393845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of clinical isolates to cephalosporins.
    Rattan A
    Indian Pediatr; 1989 Sep; 26(9):965-6. PubMed ID: 2699321
    [No Abstract]   [Full Text] [Related]  

  • 54. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
    Lang CC; Moreland TA; Davey PG
    J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefuroxime in pediatric practice. Committee on Infectious Diseases and Immunization, Canadian Paediatric Society.
    Can Med Assoc J; 1984 Oct; 131(8):877, 880. PubMed ID: 6488118
    [No Abstract]   [Full Text] [Related]  

  • 56. Cefuroxime concentrations in serum, joint fluid and bone in elderly patients undergoing arthroplasty after administration of cefuroxime axetil.
    Renneberg J; Christensen OM; Thomsen NO; Tørholm C
    J Antimicrob Chemother; 1993 Nov; 32(5):751-5. PubMed ID: 8125839
    [No Abstract]   [Full Text] [Related]  

  • 57. Anaphylactic reaction due to cefuroxime axetil: A rare cause of anaphylaxis.
    Del Villar-Guerra P; Moreno Vicente-Arche B; Castrillo Bustamante S; Santana Rodríguez C
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):731-733. PubMed ID: 27531605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefuroxime axetil: management of adult sinusitis in the clinic.
    Lund VJ; Whittet H
    J Chemother; 1989 Jul; 1(4 Suppl):763-4. PubMed ID: 16312628
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and tolerance of cefuroxime axetil: an overview of the Italian experience.
    Lechi A; Ghidini O; Dal Negro R; Cattini GC; Bezzi E
    J Chemother; 1989 Jul; 1(4 Suppl):646-7. PubMed ID: 16312573
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pharmacokinetics of cefuroxime-axetil administered by the oral route in the elderly].
    Veyssier P; Darchis JP; Devillers A
    Therapie; 1988; 43 Suppl 4():355-9. PubMed ID: 3222776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.